These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17245025)

  • 1. Too much bone: the middle ear in sclerosing bone dysplasias.
    Hamersma H; Hofmeyr L
    Adv Otorhinolaryngol; 2007; 65():61-67. PubMed ID: 17245025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerosing bone dysplasias: neurologic assessment and management.
    Hofmeyr LM; Hamersma H
    Curr Opin Otolaryngol Head Neck Surg; 2004 Oct; 12(5):393-7. PubMed ID: 15377950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal bone histopathology of osteopetrosis.
    Suga F; Linsay JR
    Ann Otol Rhinol Laryngol; 1976; 85(1 Pt 1):15-24. PubMed ID: 1083183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopetrosis of the temporal bone.
    Hawke M; Jahn AF; Bailey D
    Arch Otolaryngol; 1981 May; 107(5):278-82. PubMed ID: 7224945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Van Buchem disease: lifetime evolution of radioclinical features.
    Vanhoenacker FM; Balemans W; Tan GJ; Dikkers FG; De Schepper AM; Mathysen DG; Bernaerts A; Hul WV
    Skeletal Radiol; 2003 Dec; 32(12):708-18. PubMed ID: 14520501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.
    Sebastian A; Loots GG
    Metabolism; 2018 Mar; 80():38-47. PubMed ID: 29080811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).
    Balemans W; Ebeling M; Patel N; Van Hul E; Olson P; Dioszegi M; Lacza C; Wuyts W; Van Den Ende J; Willems P; Paes-Alves AF; Hill S; Bueno M; Ramos FJ; Tacconi P; Dikkers FG; Stratakis C; Lindpaintner K; Vickery B; Foernzler D; Van Hul W
    Hum Mol Genet; 2001 Mar; 10(5):537-43. PubMed ID: 11181578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerosteosis involving the temporal bone: clinical and radiologic aspects.
    Nager GT; Stein SA; Dorst JP; Holliday MJ; Kennedy DW; Diehn KW; Jabs EW
    Am J Otolaryngol; 1983; 4(1):1-17. PubMed ID: 6673595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of sclerosteosis.
    Hamersma H; Gardner J; Beighton P
    Clin Genet; 2003 Mar; 63(3):192-7. PubMed ID: 12694228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21.
    Balemans W; Van Den Ende J; Freire Paes-Alves A; Dikkers FG; Willems PJ; Vanhoenacker F; de Almeida-Melo N; Alves CF; Stratakis CA; Hill SC; Van Hul W
    Am J Hum Genet; 1999 Jun; 64(6):1661-9. PubMed ID: 10330353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene.
    Balemans W; Cleiren E; Siebers U; Horst J; Van Hul W
    Bone; 2005 Jun; 36(6):943-7. PubMed ID: 15869924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerosteosis: Report of type 1 or 2 in three Indian Tamil families and literature review.
    Whyte MP; Deepak Amalnath S; McAlister WH; Pedapati R; Muthupillai V; Duan S; Huskey M; Bijanki VN; Mumm S
    Bone; 2018 Nov; 116():321-332. PubMed ID: 30077757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling.
    ten Dijke P; Krause C; de Gorter DJ; Löwik CW; van Bezooijen RL
    J Bone Joint Surg Am; 2008 Feb; 90 Suppl 1():31-5. PubMed ID: 18292354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe middle ear anomaly with underdeveloped facial nerve. A temporal bone histopathologic case report.
    Kodama A; Sando I; Myers EN; Hashida Y
    Arch Otolaryngol; 1982 Feb; 108(2):93-8. PubMed ID: 7059320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathoembryology of the middle ear.
    Nadol JB
    Birth Defects Orig Artic Ser; 1980; 16(4):181-209. PubMed ID: 7016215
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analyses of the clinical characteristics of unilateral conductive hearing loss with intact tympanic membrane].
    Tang C; Zhang J; Han W; Shen W; Liu J; Hou Z; Dai P; Yang S; Han D
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 51(5):348-54. PubMed ID: 27220294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three novel mutations in the ANK membrane protein cause craniometaphyseal dysplasia with variable conductive hearing loss.
    Kornak U; Brancati F; Le Merrer M; Lichtenbelt K; Höhne W; Tinschert S; Garaci FG; Dallapiccola B; Nürnberg P
    Am J Med Genet A; 2010 Apr; 152A(4):870-4. PubMed ID: 20358596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial nerve problems and hearing loss in patients with temporal bone fractures: demographic data.
    Yetiser S; Hidir Y; Gonul E
    J Trauma; 2008 Dec; 65(6):1314-20. PubMed ID: 19077620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin deficiency in humans.
    van Lierop AH; Appelman-Dijkstra NM; Papapoulos SE
    Bone; 2017 Mar; 96():51-62. PubMed ID: 27742500
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.